Ifp Advisors, Inc Cti Biopharma Corp Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 23, 2019	SELL	$0.73 - $2.19 $1 - $4	-2 Closed	0 $0
Q4 2017 Jan 24, 2018	SELL	$2.47 - $3.34 $274 - $370	-111 Reduced 98.23%	2 $0
Q3 2017 Oct 30, 2017	SELL	$3.12 - $3.65 $9 - $10	-3 Reduced 2.59%	113 $0
Q1 2017 Jun 03, 2019	BUY	N/A	116	116 $0

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.